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Background: Marfan syndrome (MFS) is a disorder of the connective tissues. Alterations of the elastic fibers may
manifest in different tissues especially in the skeletal, cardiovascular and ocular system. Oral manifestations like
orthodontic or skeletal anomalies and fragility of the temporomandibular joint have been well described by various
authors. However, no data are available regarding a possible periodontal involvement of MFS. Hence, the aim of
the present study was to investigate for the first time if MFS may increase the susceptibility to periodontitis.
Methods: A comprehensive periodontal examination including documentation of probing pocket depth, gingival
recession, clinical attachment level, and bleeding on probing was conducted in all patients. In addition, dental
conditions were assessed by determining the Index for Decayed, Missing and Filled Teeth (DMFT) and a self-
administered questionnaire was filled out by patients. For statistical analysis, the unpaired t-Test was applied (level
of significance: p < 0.05). Both groups were matched concerning well known periodontal risk factors like age,
gender and smoking habits.
Results: 82 participants, 51 patients with MFS (30 female and 21 male, mean age: 40.20 ± 15.35 years) and 31 sound
controls (17 female and 14 male, mean age: 40.29 ± 13.94 years), were examined. All assessed periodontal and
dental parameters were not significantly different between groups.
Conclusions: Based on our data, patients with MFS did not reveal a higher prevalence of periodontitis compared
to the control group. However, Marfan patients showed a tendency to more inflammation signs, which can
be explained by the crowded teeth. Therefore, a regular professional cleaning of the teeth is recommendable
(i.e., 6 months intervals) in order to reduce the bacterial biofilm in the oral cavity and thus resulting in a
decreased risk of systemic diseases, specifically endocarditis.
Keywords: Marfan syndrome, Periodontal conditions, Periodontitis, Inflammation signs, Attachment-loss,
Dental conditions, Oral manifestationsBackground
Marfan syndrome (MFS), firstly described in 1896 by
Antoine-Bernard Marfan [1], is an autosomal dominant
disorder affecting the connective tissues. The prevalence
of Marfan syndrome is 1 per 5,000 [2]. Mutations in the
fibrillin-1 gene on chromosome 15 are responsible for
alterations of the glycoprotein fibrillin-1, a major com-
ponent of the 10–12 nm microfibrils present in the con-
nective tissue matrices [2,3]. These microfibrils, together* Correspondence: rahman.alexander@mh-hannover.de
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distribution, and reproduction in any mediumwith elastin form the elastic fibers found in various tis-
sues, including the suspensory ligament of the lens, skel-
etal system, lungs, blood vessel walls, and the skin [4].
Thus, MFS is a multisystemic disease where localization
and degree of symptoms are individually different. Some
clinical manifestations are characteristic for MFS, e.g., a
positive wrist sign (Figure 1), tall stature, aortic dissec-
tion, mitral valve prolapse, and ectopia lentis [5]. Car-
diovascular complications, especially aortic dissection
or ruptures, are the major cause of morbidity and mor-
tality [5,6]. Although genetic tests are available, the
diagnostic criteria of the current Ghent nosology still
require clinical manifestations for final diagnosis [7].tral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 A positive wrist sign in a patient with Marfan
syndrome. In case of a positive wrist sign the thumb and little
finger overlap, when grasping the wrist of the opposite hand.
Staufenbiel et al. BMC Oral Health 2013, 13:59 Page 2 of 5
http://www.biomedcentral.com/1472-6831/13/59In addition to the aforementioned multisystemic mani-
festations, MFS exhibits characteristic oral features in-
cluding maxillary protrusion, high palate (Figure 2A),
crowded teeth (Figure 2B), and fragility of the tem-
poromandibular joint [8,9].
Only scarce data are available about periodontal condi-
tions in patients with MFS. Except for De Coster et al.
[10] all publications are case reports [11-13]. Periodontal
manifestations, a higher prevalence of gingivitis and/or
periodontitis in patients with MFS may be considered
because of the high concentration of elastic fibers in the
periodontal ligament. Gingivitis and periodontitis are
chronic inflammatory diseases of the tooth supporting
tissues (periodontium) caused by bacteria of the oral
cavity that accumulate on the teeth thus forming a bio-
film [14]. The prevalence of gingivitis in the western
populations is almost 75%. Approximately 30% of adults
in the United States reveal moderate forms of periodon-
titis and 10% of the US-population is affected by severe
forms of this disease [15]. Bacterial biofilm is theFigure 2 Characteristic oral findings (high palate and crowded teeth)
jaw in a patient with Marfan syndrome. B Occlusal view of the lower jaw inprimary risk factor of gingivitis and periodontitis. But
there are secondary genetic and so called alterable (pa-
tient-specific) risk factors as well, which affect host spe-
cific immune response and metabolism of the tooth
supporting tissues [16]. These risk factors can be sum-
marized as ‘susceptibility factors’ to periodontitis.
Therefore, the objective of the present case control
study was to analyze if the mutated elastic fibers and the
extracellular matrix metabolism and composition changes
in the periodontal ligament in patients suffering from
MFS may increase the susceptibility to periodontitis: The
question which was to be answered was do patients with
MFS reveal significantly more periodontal damage and in-
flammation signs? The hypothesis that was set forth was
that patients with MFS have a higher prevalence of
periodontitis.
Methods
In accordance with the Declaration of Helsinki, the
present study was approved by the Ethical Committee
of Hannover Medical School (No. 5113) and the Ethical
Committee of the Medical Association of Hamburg
(No. MC-120/10). The study was designed as a multi-
center case control study.
Patients
A total of 82 participants, 51 patients with clinically and
genetically verified MFS and 31 control persons without
systemic diseases were included in the study. Most pa-
tients with MFS were recruited by the interdisciplinary
Marfan consultation group of the University Medical
Center, Hamburg-Eppendorf. In addition, few patients
were recruited by the Institute of Human Genetics of
Hannover Medical School or via the official website of
the German Marfan-Hilfe e.V.
Exclusion criteria for both groups were: (1) systemic
diseases that may negatively influence periodontal condi-
tions (e.g. diabetes mellitus or infectious diseases likewithout periodontal abnormalities. A Occlusal view of the upper
a patient with Marfan syndrome.
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history of drug abuse.
Both groups were matched concerning well known
periodontal risk factors like age, gender, and smoking
habits.
Detailed instructions were given to the patients includ-
ing an information brochure explaining the study design.
All subjects signed an informed consent form. The in-
vestigations were conducted between October 2010 and
November 2011.
Questionnaire
A questionnaire was handed out in the Marfan group to
ask about systemic manifestations of MFS and Marfan
specific surgical interventions. In addition, patients were
asked about a previous orthodontic treatment, frequency
of dentist visit, and disorders of the temporomandibular
joint.
Periodontal examination
All patients underwent a comprehensive periodontal exam-
ination including probing pocket depth (PPD), gingival re-
cession (GR), clinical attachment level (CAL), and bleeding
on probing (BOP) assessed at six sites per tooth (disto-
buccal, buccal, mesio-buccal, mesio-oral, oral, disto-oral).
All measurements were carried out by two calibrated ex-
perienced investigators using a pressure-calibrated probe
(TPS probe, Vivacare, Schaan, Liechtenstein). The tip of
the probe had a diameter of 0.5 mm and the probing force
was set at 20 g. Depending on PPDs the Periodontal
Screening Index (PSI) was determined [17]. The degree of
tooth mobility [18] and for multi-rooted teeth the degree
of furcation involvement [19] was documented. Mean
number and highest degree of tooth mobility and furca-
tion involvement as well were calculated.
Dental examination
A dental examination was performed in all patients in-
cluding fillings, caries, crowns, and missing teeth. All
decayed, missing, filled teeth and surfaces were summed
up and the Index for ‘Decayed’, ‘Missing’ and ‘Filled
Teeth’ (DMF-T) as well as ‘Surfaces’ (DMF-S), was
calculated [20].
Statistical analysis
The recorded data were documented and analysed by
the data procession program SPSS 19.0 for Windows
(SPSS, Chicago, IL, USA). Each individual subject counted
as a statistical unit of all tests. Mean and range values
were calculated for all parameters. The unpaired t-Test
was applied to determine significant differences between
the groups. For all tests a p-value of p ≤ 0.05 was consid-
ered to be statistically significant. The questionnaire was
analysed descriptively.Results
A total of 82 patients, 51 patients with MFS (30 female
and 21 male, mean age: 40.20 ± 15.35 years) and 31 con-
trols (17 female and 14 male, mean age: 40.29 ± 13.94 years),
were examined.
Questionnaire
Regarding systemic manifestations of MFS, 88% of the
Marfan patients had an involvement of the cardiovascu-
lar system, 72% of the skeletal system, and 62% of the
optical system. 74% of the Marfan patients had previ-
ously undergone surgical interventions, mostly due to
cardiovascular diseases.
With respect to the frequency of dentist visit, 52.9% of
the Marfan patients attended dental examination twice a
year, whereas 33.3% visited a dental office only annually.
The remaining patients were examined three times a
year (7.8%) or irregularly (5.9%).
39.2% of the Marfan patients were affected by disor-
ders of the temporomandibular joint and 62% had a pre-
vious orthodontic treatment.
Periodontal examination
Mean and range values of all periodontal parameters
(PPD, GR, CAL, BOP, PSI, degree of tooth mobility, de-
gree of furcation involvement) are presented in Table 1.
All assessed periodontal parameters were not signifi-
cantly different between the groups. The Marfan group
showed almost similar readings compared to the control
group such as mean PPDs (2.33 ± 0.43 mm vs. 2.39 ±
0.40 mm) as well as mean GR readings (0.33 ± 0.34 mm
vs. 0.31 ± 0.33 mm), mean CAL (2.62 ± 0.56 mm vs.
2.70 ± 0.61 mm), PSI (3.18 ± 0.79 vs. 3.1 ± 0.65), mean
number of mobile teeth (0.14 ± 0.69 vs. 0.55 ± 1.93),
and mean number of teeth with furcation involvement
(1.86 ± 3.49 vs. 2.94 ± 5.12). The inflammation index
BOP showed only a slight tendency to be higher in the
Marfan group (21.58 ± 13.24% vs. 17.53 ± 11.63%).
Dental examination
DMF-T and DMF-S were not significantly different be-
tween groups. Mean and range values are given in
Table 2.
Discussion
Systemic manifestations and clinical characteristics of pa-
tients with MFS are well described by various authors.
Data about oral manifestations of MFS such as maxillary
protrusion, high palate, narrowed arch, crowding of the
teeth, and fragility of the temporomandibular joint are
consistent [8,9]. However, to date there is no data available
in the dental/medical literature demonstrating a higher
prevalence of periodontitis or more severe types of
periodontitis in Marfan patients. Overall, various authors
Table 1 Mean and range values of all assessed clinical
periodontal parameters and comparison of mean values
(unpaired t-Test)
Clinical parameter Marfan
group (n = 51)
Control
group (n = 31)
Probing pocket depth (in mm) 2.33 ± 0.43* 2.39 ± 0.40
Gingival recession (in mm) 0.33 ± 0.34* 0.31 ± 0.33
Clinical attachment level (in mm) 2.62 ± 0.56* 2.70 ± 0.61
Periodontal screening index 3.18 ± 0.79* 3.10 ± 0.65
Highest degree of furcation
involvement
0.55 ± 0.88* 0.68 ± 0.87
Number of teeth with furcation
involvement
1.86 ± 3.49* 2.94 ± 5.12
Highest degree of tooth mobility 0.78 ± 0.39* 0.13 ± 0.34
Number of mobile teeth 0.14 ± 0.69* 0.55 ± 1.93
Bleeding on probing (in %) 21.58 ± 13.24* 17.53 ± 11.63
*No statistically significant differences compared to the control
group (p > 0.05).
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patients [12,21,22]. These studies always refer to reports pub-
lished by Straub et al. [11] or De Coster et al. [10]. However
it needs to be considered that Straub et al. reported only one
case of severe periodontitis in MFS and De Coster et al. did
not analyse the prevalence of periodontitis but only gingival
inflammations. Therefore, the present study analysed for the
first time the association of MFS with the prevalence and se-
verity of periodontitis with an all-time sample size.
Firstly, our data do not indicate more periodontal dam-
age, a higher prevalence or more severe forms of peri-
odontitis in patients with MFS. Mean CAL and PSI were
almost similar in the Marfan group compared to the
sound controls. Several case reports [11-13] presented
Marfan patients with gingival or periodontal abnormal-
ities. In particular, Straub et al. [11] documented one case
of MFS with severe periodontitis. But it must be kept in
mind that the cause of attachment loss is multifactorial.
Beside patient-specific risk factors like smoking, oral hy-
giene, nutrition, obesity, etc. there are patients with a
genetic predisposition, which is up to now not well
understood [23-26]. For example, ethnical origin may
be an important risk factor. Africans suffer more fre-
quently from so called aggressive forms of periodontitis
[24]. Therefore, it may be concluded that a geneticTable 2 Mean and range values of DMF-T and DMF-S and







DMF-T 14.55 ± 7.26* 13.71 ± 6.84
DMF-S 45.45 ± 31.34* 42.55 ± 32.16
*No statistically significant differences compared to the control
group (p > 0.05).predisposition and/or patient-specific periodontal risk
factors independent from MFS may have been respon-
sible for the severe periodontitis in the patient pre-
sented by Straub et al. [11].
Secondly, our data do not reveal significant differences
rather than a slight tendency of more periodontal in-
flammation in Marfan patients compared to the control
group. De Coster et al. [10] investigated 23 Marfan pa-
tients and compared dental and gingival conditions with
69 sound control patients. According to the results of
the present study, De Coster et al. revealed more peri-
odontal inflammation in Marfan patients compared to
the control group (Gingiva Index in the Marfan group:
1.9 vs. 1.0 in the control group). However, De Coster
et al. used a less reproducible index called Gingiva
Index, which only assesses gingival inflammation signs
by inspection. While interpreting the higher degree of
inflammation, one has to keep in mind that Marfan pa-
tients suffer more frequently from a crowding of the
teeth compared to sound persons. Crowded teeth are
much more difficult to clean during patient’s oral hy-
giene. Thus, plaque accumulation and consequently
periodontal inflammation is much more pronounced.
Therefore, the higher degree of inflammation in patients
with MFS may have been the result of crowded teeth.
Thirdly, the results of the dental examination revealed
no elevated numbers of decayed, missing or filled teeth
in the Marfan group compared to the control group.
DMF-T and DMF-S were almost identical in both groups.
This is confirmed by De Coster et al. [10], who also did
not find significant differences between the mean DMF-T
in 23 Marfan patients compared to 69 controls.
The analysis of the questionnaire revealed a relatively
high prevalence of disorders of the temporomandibular
joint, which is in accordance with other studies [8,9,27,28].
For instance, Bauss et al. [9] documented that 51.6% of
281 Marfan patients suffered from disorders of the tem-
poromandibular joint. Westling et al. [8] reported a preva-
lence of 54% in 76 Marfan patients. Therefore, the
temporomandibular joint is one of the main maxillo-
facial structures that are affected by the MFS. It may
be concluded that orthodontic or skeletal anomalies
like maxillary protrusion, high palate, or crowded teeth
are responsible for the relatively high frequency of
orthodontic treatment in Marfan patients due to our
study (62%) and previous investigations [8,19]. De
Coster et al. [10] analysed kephalometric data in 26
Marfan patients. They concluded based on their data
that the need for orthodontic treatment in patients
with MFS is significantly higher to sound controls.
Although the present study did not demonstrate a
higher susceptibility to periodontitis and revealed only a
slight tendency of more periodontal inflammation in pa-
tients with MFS one has to consider the increased risk
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higher risk for endocarditis is not the result of the disease
but the consequence of a prosthetic valve or other prosthetic
materials that are implanted in patients with MFS in order
to treat cardiovascular complications. Therefore, an ad-
equate dental monitoring and regular professional cleaning
are recommended because of the higher number of patients
with prosthetic valves suffering from Marfan syndrome.
Conclusion
Based on our data, patients with Marfan syndrome do
not suffer from more decayed, missing or filled teeth.
The prevalence of disorders of the temporomandibular
joint seems to be higher in Marfan patients then in pa-
tients without MFS. MFS patients do not reveal more
periodontal damage, a higher prevalence of periodontitis
or suffer more frequently from severe forms of peri-
odontitis (e.g. aggressive periodontitis). It may be con-
cluded that the mutation associated with MFS does not
predispose the periodontal ligament to a higher suscepti-
bility to periodontitis. Further, crowded teeth may be the
reason for a slight tendency towards more periodontal
inflammation in Marfan patients. Taken together, it is
recommended that Marfan patients should receive a
professional oral hygiene on a regular basis due to their
increased risk of endocarditis based on the high number
of Marfan patients with prosthetic heart valves.
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